Kidney cancer: Past, present, and future

被引：21

作者：

Novick, Andrew C. ^{[1
]}

机构：

[1] Cleveland Clin Fdn, Glickman Urol Inst, Cleveland, OH 44195 USA

来源：

UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS | 2007年 / 25卷 / 03期

关键词：

D O I：

10.1016/j.urolonc.2007.03.006

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

[No abstract available]

引用

页码：188 / 195

页数：8

共 41 条

[31] Activity of SU11248, a multitargeted inhibitor of vascular endothelial growth factor receptor and platelet-derived growth factor receptor, in patients with metastatic renal cell carcinoma [J].

Motzer, RJ ;

Michaelson, MD ;

Redman, BG ;

Hudes, GR ;

Wilding, G ;

Figlin, RA ;

Ginsberg, MS ;

Kim, ST ;

Baum, CM ;

DePrimo, SE ;

Li, JZ ;

Bello, CL ;

Theuer, CP ;

George, DJ ;

Rini, BI .

JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (01) :16-24

[32] Sunitinib versus interferon alfa in metastatic renal-cell carcinoma [J].

Motzer, Robert J. ;

Hutson, Thomas E. ;

Tomczak, Piotr ;

Michaelson, M. Dror ;

Bukowski, Ronald M. ;

Rixe, Olivier ;

Oudard, Stephane ;

Negrier, Sylvie ;

Szczylik, Cezary ;

Kim, Sindy T. ;

Chen, Isan ;

Bycott, Paul W. ;

Baum, Charles M. ;

Figlin, Robert A. .

NEW ENGLAND JOURNAL OF MEDICINE, 2007, 356 (02) :115-124

[33] LONG-TERM FOLLOW-UP AFTER PARTIAL REMOVAL OF A SOLITARY KIDNEY [J].

NOVICK, AC ;

GEPHARDT, G ;

GUZ, B ;

STEINMULLER, D ;

TUBBS, RR .

NEW ENGLAND JOURNAL OF MEDICINE, 1991, 325 (15) :1058-1062

[34] Nephron-sparing surgery for renal cell carcinoma [J].

Novick, AC .

ANNUAL REVIEW OF MEDICINE, 2002, 53 :393-407

[35] EFFECT OF ANGIOTENSIN-CONVERTING ENZYME-INHIBITION ON NEPHROPATHY IN PATIENTS WITH A REMNANT KIDNEY [J].

NOVICK, AC ;

SCHREIBER, MJ .

UROLOGY, 1995, 46 (06) :785-789

[36] Safety and efficacy of partial nephrectomy for all T1 tumors based on an international multicenter experience [J].

Patard, JJ ;

Shvarts, O ;

Lam, JS ;

Pantuck, AJ ;

Kim, HL ;

Ficarra, V ;

Cindolo, L ;

Han, KR ;

De la Taille, A ;

Tostain, J ;

Artibani, W ;

Abbou, CC ;

Lobel, B ;

Chopin, DK ;

Figlin, RA ;

Mulders, PFA ;

Belldegrun, AS .

JOURNAL OF UROLOGY, 2004, 171 (06) :2181-2185

[37] Long-term survival analysis after laparoscopic radical nephrectomy [J].

Permpongkosol, S ;

Chan, DY ;

Link, RE ;

Sroka, M ;

Allaf, M ;

Varkarakis, I ;

Lima, G ;

Jarrett, TW ;

Kavoussi, LR .

JOURNAL OF UROLOGY, 2005, 174 (04) :1222-1225

[38] Initial evaluation of Cyberknife technology for extracorporeal renal tissue ablation [J].

Ponsky, LE ;

Crownover, RL ;

Rosen, MJ ;

Rodebaugh, RF ;

Castilla, EA ;

Brainard, J ;

Cherullo, EE ;

Novick, AC .

UROLOGY, 2003, 61 (03) :498-501

[39] A postoperative prognostic nomogram predicting recurrence for patients with conventional clear cell renal cell carcinoma [J].

Sorbellini, M ;

Kattan, MW ;

Snyder, ME ;

Reuter, V ;

Motzer, R ;

Goetzl, M ;

McKiernan, J ;

Russo, P .

JOURNAL OF UROLOGY, 2005, 173 (01) :48-51

[40] A randomized trial of bevacizumab, an anti-vascular endothelial growth factor antibody, for metastatic renal cancer [J].

Yang, JC ;

Haworth, L ;

Sherry, RM ;

Hwu, P ;

Schwartzentruber, DJ ;

Topalian, SL ;

Steinberg, SM ;

Chen, HX ;

Rosenberg, SA .

NEW ENGLAND JOURNAL OF MEDICINE, 2003, 349 (05) :427-434

← 1 2 3 4 5 →